These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7966162)

  • 1. Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.
    Kim HO; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1994 Nov; 37(23):4020-30. PubMed ID: 7966162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
    Kim HO; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1994 Sep; 37(20):3373-82. PubMed ID: 7932565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
    Jacobson KA; Siddiqi SM; Olah ME; Ji XD; Melman N; Bellamkonda K; Meshulam Y; Stiles GL; Kim HO
    J Med Chem; 1995 May; 38(10):1720-35. PubMed ID: 7752196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
    Kim HO; Ji XD; Siddiqi SM; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1994 Oct; 37(21):3614-21. PubMed ID: 7932588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A binding site model and structure-activity relationships for the rat A3 adenosine receptor.
    van Galen PJ; van Bergen AH; Gallo-Rodriguez C; Melman N; Olah ME; IJzerman AP; Stiles GL; Jacobson KA
    Mol Pharmacol; 1994 Jun; 45(6):1101-11. PubMed ID: 8022403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
    Gallo-Rodriguez C; Ji XD; Melman N; Siegman BD; Sanders LH; Orlina J; Fischer B; Pu Q; Olah ME; van Galen PJ
    J Med Chem; 1994 Mar; 37(5):636-46. PubMed ID: 8126704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
    van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
    Siddiqi SM; Jacobson KA; Esker JL; Olah ME; Ji XD; Melman N; Tiwari KN; Secrist JA; Schneller SW; Cristalli G
    J Med Chem; 1995 Mar; 38(7):1174-88. PubMed ID: 7707320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
    Karton Y; Jiang JL; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1996 Jun; 39(12):2293-301. PubMed ID: 8691424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
    Jiang JL; van Rhee AM; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1996 Nov; 39(23):4667-75. PubMed ID: 8917655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
    Kim YC; Ji XD; Jacobson KA
    J Med Chem; 1996 Oct; 39(21):4142-8. PubMed ID: 8863790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of flavonoids and other phytochemicals with adenosine receptors.
    Ji XD; Melman N; Jacobson KA
    J Med Chem; 1996 Feb; 39(3):781-8. PubMed ID: 8576921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
    Shearman LP; Weaver DR
    Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1998 Aug; 41(17):3186-201. PubMed ID: 9703464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
    Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
    J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and Desensitization of Rat A
    Park KS; Hoffmann C; Kim HO; Padgett WL; Daly JW; Brambilla R; Motta C; Abbracchio MP; Jacobson KA
    Drug Dev Res; 1998 Jun; 44(2-3):97-105. PubMed ID: 23487508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    Jiang J; van Rhee AM; Chang L; Patchornik A; Ji XD; Evans P; Melman N; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2596-608. PubMed ID: 9258367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.